Power3 Comments on Market Activity


THE WOODLANDS, Texas, Aug. 19, 2004 (PRIMEZONE) -- Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company, has issued this press release to inform its shareholders and other interested parties that it has come to management's attention that there have been messages left on answering machines purporting to convey information about Power3 Medical Products. The Company is not a party to any of these activities, nor approves of them.

The Company believes that the recent volatility in the volume and stock price may be due to this activity. Power3 Medical refers investors and interested parties to the website at www.power3medical.com for a complete and accurate description of the business. Additionally, on the website you will find all authorized company press releases issued since May 18, 2004, as well as a link to the Securities and Exchange Commission's website where you can view all public filings made with the Securities and Exchange Commission.

Power3 Medical Products is a leading proteomics company engaged in the discovery of protein footprints, pathways, and mechanisms of diseases. The Company's patent pending technologies are being used to develop screening and diagnostic tests for the early detection and treatment of disease. The Company's identified protein biomarkers, drug targets, and diagnostic tests are targeted toward markets with critical unmet needs in areas such as breast cancer and neurodegenerative disease.

Safe Harbor Statement

All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.



            

Contact Data